STOCK TITAN

Intercept to Present at the Raymond James 2021 Human Health Innovation Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq:ICPT) announced that Jerry Durso, President and CEO, will present at the Raymond James 2021 Human Health Innovation Conference on June 22, 2021, at 1:20 p.m. ET. A live webcast will be accessible on the investor page of Intercept's website, with an audio archive available for two weeks post-event. Intercept focuses on developing therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis. Founded in 2002, the company operates in the U.S., Europe, and Canada.

Positive
  • None.
Negative
  • None.

NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the Raymond James 2021 Human Health Innovation Conference on Tuesday, June 22, 2021 at 1:20 p.m. ET.

A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:  investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.


FAQ

When is the Raymond James 2021 Human Health Innovation Conference presentation by Intercept Pharmaceuticals?

The presentation is scheduled for June 22, 2021, at 1:20 p.m. ET.

How can I watch the Intercept Pharmaceuticals conference presentation?

The presentation can be viewed live on the investor page of Intercept's website.

What is the focus of Intercept Pharmaceuticals?

Intercept Pharmaceuticals specializes in therapeutics for progressive non-viral liver diseases.

What diseases does Intercept Pharmaceuticals target?

Intercept targets primary biliary cholangitis and nonalcoholic steatohepatitis.

When will the audio archive of the webcast be available?

The audio archive will be available for approximately two weeks after the event.

Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

ICPT Rankings

ICPT Latest News

ICPT Stock Data

794.69M
40.45M
3.13%
81.3%
24.24%
Biotechnology
Healthcare
Link
United States
Morristown